【レポートの概要（一部）】
1. Report Overview
1.1 Leading Contract Manufacturing Organisations (CMOs) Overview
1.2 Benefits of This Report
1.3 How This Report Delivers Information
1.4 Main Questions This Report Answers
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Related Reports
1.9 About Visiongain
2. Introduction to Pharmaceutical Contract Manufacturing, 2016
2.1 What Services Do Contract Manufacturers Offer?
2.1.1 Why Do Firms Outsource Manufacturing?
2.1.2 What Is Driving Demand for Contract Manufacturing Services?
2.2 The Pharmaceutical Contract Manufacturing Market, 2015
2.2.1 Where is Supply and Demand Highest for Contract Manufacturing Services?
2.3 Outlook for the Pharmaceutical Contract Manufacturing Market 2016-2026
2.4 Driving and Restrictive Forces for Pharmaceutical Contract Manufacturing, 2016-2026
2.4.1 Pharmaceutical Contract Manufacturing: Market Drivers 2016-2026
2.4.2 Pharmaceutical Contract Manufacturing: Market Restraints 2016-2026
2.5 Who Are the Leading Pharmaceutical Contract Manufacturers in 2015?
3. Leading CMOs in North America
3.1 Catalent Pharma Solutions- the World’s Leading CMO
3.1.1 Catalent: Manufacturing Services and Capabilities
3.1.2 Divisional Segmentation – Breaking Down Catalent’s Service
3.1.3 Catalent Pharma’s Revenue Growth, 2010-2014
3.1.4 Sustained Growth in Oral Products: Catalent Pharma’s Divisional Performance, 2010-2014
3.1.5 Catalent Is Expanding its Oral Technologies Division
3.1.6 Quadrupling Biopharmaceutical Manufacturing Capacity
3.1.7 Expansion of Packaging Services in Asia-Pacific and Europe: 2015
3.1.8 Adding New Early-Stage Development Services
3.1.9 Expansion in Japan – Growth Prospects for Catalent
3.1.10 New Business Contracts 2014-2015
3.1.11 Catalent New Products Launch
3.1.12 Catalent: Opportunities for Growth 2016-2026
3.1.13 Catalent: Mild Growth in Revenue, 2016-2026
3.2 Patheon – One of the Top 3 CMOs
3.2.1 Patheon – Global leader in Pharmaceutical Development Services
3.2.2 Contract Manufacturing Services at Patheon
3.2.3 Steady Revenue Growth 2010-2015
3.2.4 DPx Holdings: Developments
3.2.5 Adding New Formulations and Formulation Development Services
3.2.6 Reassessing Manufacturing Capacity
3.2.7 Expanding Services Through Acquisition, 2015
3.2.8 Patheon: SWOT Analysis 2016-2026
3.2.9 Patheon: Contract Manufacturing Revenue Forecast 2016-2026
3.3 Baxter BioPharma Solutions
3.3.1 Baxter BioPharma is the Global Leader in Sterile Fill and Finish
3.3.2 Historic Revenue Performance 2010-2015
3.3.3 Baxter BioPharma SWOT Analysis 2016-2026
3.3.4 Baxter BioPharma Revenue Forecast 2016-2026
3.4 AbbVie Contract Manufacturing
3.4.1 AbbVie Offers Full-Service Contract Manufacturing
3.4.2 Expanding and Adding New Services: 2013-2014
3.4.3 AbbVie Contract Manufacturing: Revenue 2011-2015
3.4.4 Biologics and HPAPIs Are an Opportunity for Growth 2016-2026
3.4.5 AbbVie Contract Manufacturing Revenue Forecast 2016-2026
3.5 Pfizer CentreOne
3.5.1 Pfizer CentreSource: Historic Revenue Performance, 2010-2015
3.5.2 Will Hospira Acquisition Lead to Revenue Growth in Future?
3.5.3 Outlook for CentreOne: Revenue Forecast 2016-2026
4. Leading European Contract Manufacturing Organisations
4.1 Lonza
4.1.1 Lonza Is a Leader in Biologics Manufacturing
4.1.2 Lonza Contract Manufacturing and Development: 2010-2015
4.1.3 Investing in Advanced Biological Drug Sectors
4.1.4 The Promise of Antibody-Drug Conjugates (ADCs)
4.1.5 The Regenerative Medicine Future in Japan
4.1.6 Lonza: SWOT Analysis 2016-2026
4.1.7 Biologics and Efficiency Savings Will Drive Growth in Revenue and Operating Profit for Lonza 2016-2026
4.2 Evonik Degussa
4.2.1 Investing in API and Drug Delivery Services
4.2.2 Moderate Growth in Pharmaceutical Manufacturing Services, 2010-2015
4.2.3 Evonik Is a HPAPI Specialist
4.2.4 Evonik Continues to Grow Across All Segments
4.2.5 How Can Evonik Expand in the Pharmaceutical Contract Manufacturing Market?
4.2.6 Evonik Degussa: Revenue Forecast 2016-2026
4.3 Royal DSM
4.3.1 Amplified Revenue Growth in Pharma Manufacturing 2010-2014
4.3.2 DSM Pharmaceuticals Products/DPx Holdings: Manufacturing Services 2010-2015
4.3.3 DSM Sinochem Pharmaceuticals: A World Leader in Antibacterial Manufacturing
4.3.4 DPx Holdings: A New Pharma Leader
4.3.5 Investing in Biopharma Manufacturing
4.3.6 Expanding API Manufacturing
4.3.7 Generics and Biologics Are an Opportunity for Growth, 2015-2026
4.3.8 DSM Pharmaceuticals Products: Revenue Forecast 2016-2026
4.4 Boehringer Ingelheim Contract Manufacturing
4.4.1 Expanding Biopharmaceuticals Manufacturing Services in China
4.4.2 Production Through to Fill and Finished Biopharmaceuticals
4.4.3 A Track Record of Production for 29 Biopharma Products
4.4.4 Increasing Revenue from Contract Manufacturing, 2010-2014
4.4.5 Pulling Out of Small Molecule API Manufacturing
4.4.6 Expanding through New Services
4.4.7 Boehringer Ingelheim Biopharmaceuticals: Opportunities for Growth 2016-2026
4.4.8 Boehringer Ingelheim: Revenue Forecast 2016-2026
4.5 Fareva
4.5.1 Fareva Has 35 Years’ Manufacturing Experience
4.5.2 Revenue Growth through Acquisitions: 2010-2015
4.5.3 Fareva SWOT Analysis: 2016-2026
4.5.4 Fareva Revenue Forecast: 2016-2026
4.6 Aenova Group
4.6.1 Acquisition of Haupt Creates European CMO Giant
4.6.2 Aenova’s Ever Expanding Manufacturing Capacity
4.6.3 Aenova’s Revenue 2010-2015: Organic Growth and Acquisitions
4.6.4 Aenova’s Competitive Position in the Contract Manufacturing Market: SWOT Analysis 2016
4.6.5 Becoming a Leading Contract Manufacturer: Aenova Revenue Forecast 2016-2026
4.7 Famar
4.7.1 Famar Is an Expert in Lyophilisation
4.7.2 Sustained Growth in Famar’s Revenue: 2010-2015
4.7.3 Expanding Outside Europe
4.7.4 Further Site Acquisitions Are an Opportunity for Growth 2016-2026
4.7.5 How Will Famar Perform 2016-2026?
4.8 Vetter Pharmaceutical
4.8.1 Vetter is an Injectable Manufacturing Specialist
4.8.2 Rapidly Growing Revenue in the US and Germany: 2010-2015
4.8.3 Services, Collaborations and Differentiating Factors
4.8.4 Expanding Services in US and Asia
4.8.5 Biologics Are an Opportunity for Growth for Vetter 2016-2026
4.8.6 Vetter Outlook: Revenue Forecast 2016-2026
4.9 Almac Group
4.9.1 Almac’s Manufacturing Services
4.9.2 Almac Outpaces the Market: 2011-2015
4.9.3 Almac Adding Capacity Globally
4.9.4 New Services Added 2012-2015
4.9.5 Almac Group: Contract Manufacturing Market Outlook 2016-2026
4.9.6 How Will Almac Group Perform 2016-2026?
4.10 Delpharm
4.10.1 Finished Dosage Form Manufacturing for Developed Markets
4.10.2 Delpharm: Rapid Revenue Growth Via Acquisitions, 2010-2015
4.10.3 Delpharm: Outlook and Prospects for Growth 2016-2026
4.10.4 Generics Will Drive Revenue Growth for Delpharm 2016-2026
4.11 Siegfried
4.11.1 Siegfried’s Acquisitions, 2010-2015
4.11.2 Expanding Siegfried’s Manufacturing Footprint Globally
4.11.3 Expanding High Potency API Capabilities
4.11.4 Siegfried: Financial Performance 2010-2015
4.11.5 Siegfried’s Characteristics within the Contract Manufacturing Market: SWOT Analysis 2016
4.11.6 Continued Revenue Growth for Siegfried 2016-2026
4.12 Corden Pharmaceutical
4.12.1 CordenPharma Service Division
4.12.2 CordenPharma Emerging in the API Market
4.12.3 Investments in Highly Potent Capabilities
4.12.4 CordenPharma: SWOT Analysis 2016-2026
4.13 Recipharm
4.13.1 Contract Development and Manufacturing Services
4.13.2 Recipharm: Financial Performance 2010-2015
4.13.3 Recipharm Invests in Facility Expansion
4.13.4 Recipharm Growing in the Development and Technology Market Through Acquisitions
4.13.5 Recipharm: Opportunities for Growth 2016-2026
4.13.6 Outlook for Recipharm: Revenue Forecast 2016-2026
4.14 Aesica Pharmaceuticals
4.14.1 Aesica Manufactures APIs and Finished Dosage Forms
4.14.2 Acquisitions Drive Revenue Growth but Operational Margins Have Declined, 2010-2015
4.14.3 Partnering with Academia for Innovative Solutions
4.14.4 Growth through Acquisitions and Internal Expansion
4.14.5 Aesica: Opportunities for Expansion 2016-2026
4.14.6 Forecast Aesica Financial Performance, 2016-2026
5. Leading Japanese Pharma Contract Manufacturing Organisations
5.1 Nipro Corporation: Japan’s Leading CMO
5.1.1 Nipro Pharmaceutical Contract Manufacturing Capabilities
5.1.2 Nipro: Decline in Revenue But increasing Operating Profits 2010-2015
5.1.3 Biosimilars and Anti-Cancer Drugs Are Opportunities for Future Growth: SWOT Analysis 2016-2026
5.1.4 Nipro Revenue and Profitability Forecast 2016-2026
5.2 Daito Pharmaceutical
5.2.1 Daito Has a Portfolio of More than 30 APIs
5.2.2 Rapid Growth in Revenue and Operational Profit: Daito Financial Performance 2010-2015
5.2.3 Daito Is Well-Placed for Asian Market Growth – SWOT Analysis 2016-2026
5.2.4 Sustained Growth in Revenue and Operating Profit for Daito, 2016-2026
6. Leading Developed-Market API Specialists
6.1 Teva API
6.1.1 API Manufacturing Services
6.1.2 Teva API: Financial Performance 2010-2015
6.1.3 Building a Footprint in Mexico, India and China
6.1.4 Teva API: SWOT Analysis 2016-2026
6.1.5 Outlook for Teva API: Revenue Forecast 2015-2025
6.2 Esteve Química
6.2.1 Esteve Química Manufactures APIs for Developed and Emerging Markets
6.2.2 Expanding in The US, 2015
6.2.3 Esteve Química: SWOT Analysis 2016-2026
6.3 Euticals
6.3.1 Euticals Manufactures More than 200 APIs
6.3.2 Acquisitions Drive Growth 2010-2015
6.3.3 Adding Capacity for Finished Dosage Forms
6.3.4 Asian Expansion Is an Opportunity for Growth 2016-2026
6.3.5 Euticals: Revenue Forecast 2016-2026
7. Leading Chinese Pharmaceutical Conctract Manufacturers
7.1 Zhejiang Hisun Pharmaceutical
7.1.1 API Manufacturing for Markets Worldwide
7.1.2 Zhejiang Hisun’s Rapid Growth in API Revenue Grows, 2010-2015
7.1.3 Moving Into International Drug Marketing
7.1.4 Zhejiang Hisun: Opportunities for Growth 2016-2026
7.1.5 Zhejiang Hisun: Strong API Revenue Growth 2016-2026
7.2 Zhejiang Huahai Pharmaceuticals
7.2.1 Zhejiang Huahai Is a Market Leader Within The Antihypertensive API Market
7.2.2 Zhejiang Huahai: Contract Manufacturing Performance 2010-2015
7.2.3 Expanding in the US Generic Drugs Market
7.2.4 Zhejiang Huahai: SWOT Analysis, 2016-2026
7.2.5 Zhejiang Huahai: Revenue Forecast, 2016-2026
7.3 Shandong Xinhua Pharmaceutical
7.3.1 Experience in APIs and Finished Dosage Forms
7.3.2 Shandong Xinhua: Strong Revenue Growth 2010-2015
7.3.3 Growing through Joint Ventures
7.3.4 Looking to Expand in the US and EU 2016-2026
7.3.5 Shandong Xinhua Pharmaceutical: Revenue Forecast 2016-2026
8. Leading Indian Pharmaceutical Contract Manufacturers
8.1 Aurobindo Pharma
8.1.1 API Manufacturing Services
8.1.2 Aurobindo Pharma: Steady Revenue Growth 2010-2015
8.1.3 Aurobindo Expanding Outside of Antibacterials
8.1.4 Aurobindo: Opportunities for Expansion 2016-2026
8.1.5 How Will Aurobindo’s Contract Manufacturing Division Perform 2016-2026?
8.2 Divis Laboratories
8.2.1 Divis Laboratories and the Contract Manufacturing Industry
8.2.2 Divis Laboratories: A Rapidly Growing CMO, 2010-2014
8.2.3 Divis Laboratories: API Manufacturing Outlook 2016-2026
8.2.4 Divis Laboratories: API Manufacturing Revenue Forecast, 2016-2026
8.3 Dr. Reddy’s Laboratories
8.3.1 API and FDF Manufacturing Services
8.3.2 Dr. Reddy’s PSAI: Strong Revenue Growth 2011-2015
8.3.3 Advancing in Complex Drug Manufacturing
8.3.4 Expanding in the European Manufacturing Market
8.3.5 Dr. Reddy’s PSAI Division: Revenue Forecast 2016-2026
9. Conclusions of the Study
9.1 What Has Driven Growth for CMO Market Leaders in Recent Years?
9.2 Strategies for Growth: Prospects For Leading CMOs, 2016-2026
9.3 High Demand for Biopharmaceutical Manufacturing Services
9.4 Investing in Novel Technologies
9.5 Outlook for API Manufacturers
【レポート販売概要】
■ タイトル：医薬品リーダーシリーズ：医薬品製造受託機関（CMO）上位30社2016-2026■ 英文：Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026
■ 発行日：2016年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN61121
■ 調査対象地域：グローバル
- スクーク（イスラム債券）の世界市場2016-2020About Sukuk Sukuk comes from the word "sakk" which is considered an investment certificate that follows Islamic financing principles. The sukuk helps to facilitate trade transactions as this serves as a promissory note among merchants. The issuer of the sukuk sells the certificate to an investor group. This investor group rents the certificate back to the issuer at a predetermined fee. The issuer …
- 保護継電器の世界市場2016-2020About Relays A device that senses the quantity of current flowing in the supply lines before entering the power system of the equipment or motor can prevent the motor from damage. A relay is one such electromechanical device that is actuated by electrical current. In a relay, the current flowing in one circuit causes the opening and closing of another circuit. Due to the simplicity, long life, and …
- 世界の万引き防止システム・タグ市場動向（2012-2016）TechNavio's analysts forecast the Global Electronic Article Surveillance Systems market to grow at a CAGR of 2.88 percent over the period 2012-2016. One of the key factors contributing to this market growth is the robust growth in the global retail market. The Global Electronic Article Surveillance Systems market has also been witnessing the emerging source tagging in the retail sector. However, t …
- 糖鎖生物学グライコミクス/グリコバイオロジーの世界市場予測（～2021）：製品別（酵素（グリコシルトランスフェラーゼ、グリコシダーゼ）、機器別（高速液体クロマトグラフィー(HPLS)、質量分析、マトリックス支援レーザー脱離イオン化-飛行時間型質量分析(MALDITOF)）、キットおよび試薬別（糖タンパク質））、用途別（診断、創薬、腫瘍学）、エンドユーザー 別The global glycomics/glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented on the basis of product, application, end user, and region. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotech …
- 世界及び中国の高強度ポリエステル糸市場2015The Global and China High-strength polyester Thread Industry 2015 Market Research Report is a professional and in-depth study on the current state of the High-strength Polyester Thread industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The High-strength Polyester Thread market analysis is provided for th …
- Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 – Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive GrowthChronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report “Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant …
- 携帯端末管理（MDM）：インフラ及びサービス2014-2019（Mobile Device Management (MDM): Infrastructure and Services 2014 – 2019）Mobile Device Management (MDM) represents solutions that secure, monitor, manage and support mobile/wireless devices deployed across mobile network operators (MNO), other service providers and enterprise companies. MDM is a useful tool for a MNO to manage the many different device types across their network. It is also useful for MNO to manage periodically required device updates and administratio …
- ユーカリ精油（エッセンシャルオイル）の世界市場2019-2023About this market The demand for natural products is increasing owing to health concerns among consumers. Consumers are interested in being aware about the ingredients in skin care and food and beverage products, and they are showing an increased preference for natural products. This has increased the demand for eucalyptus essential oil. The emergence of several global and regional food manufactur …
- 食品サービス向けパッケージングの世界市場予測（～2022年）“Food service packaging market projected to grow at a CAGR of 5.23%” The food service packaging market size is projected to grow at a CAGR of 5.23% during the forecast period of 2017–2022, and reach USD 84.33 billion by 2022. Food service packaging is used to package processed and semi-processed food products. The growth in demand from restaurants, fast food joints, takeaway restaurants, quick-ser …
- 電気温水器の世界市場2015-2019About electric water heaters Water heaters are one of the major consumers of energy globally. They often exceed the consumption of energy for domestic activities such as cooking, refrigeration, and lighting. Electric storage tank water heater is the most commonly used appliance for heating water. Low-income households use biofuel, coal, and other sources of energy for heating water, but more afflu …
- データセンター・コロケーションの世界市場2016-2020About Data Center Colocation A data center colocation facility allows organizations to rent space for hosting servers and storage infrastructure. It provides options such as power, bandwidth, and physical security for the infrastructure. A hosting solution managed by a service provider and owned by a client can be termed a managed hosting solution. Colocation and managed hosting services are usefu …
- 屋内LBSの世界市場2016-2020About Location-Enabled Mobile Location-enabled mobile devices include smartphones, tablets, and devices fitted in vehicles. The location of such devices is determined by a mechanism known as localization, which considers the user's browsing activities related to navigation, lifestyle, shopping, social networking, public transportation, utilities, and games. Indoor LBS provide information regarding …
- イギリスの気道装置・麻酔装置市場United Kingdom Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "United Kingdom Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the United Kingdom Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Cir …
- パテントブルーVの世界市場Patent Blue V (CAS 3536-49-0) Market Research Report 2013 presents comprehensive data on patent blue v markets globally and regionally (Europe, Asia, North America etc.) The Patent Blue V (CAS 3536-49-0) Market Research Report 2013 includes patent blue v description, covers its application areas and related patterns. It overviews patent blue v market, names patent blue v producers and indicates it …
- デジタル変電所の世界市場予測（～2022）： 送電変電所、配電変電所The digital substation market is expected to be valued at USD 8.42 Billion by 2022, growing at a CAGR of 6.8% between 2016 and 2022. Several countries are looking for reliable and stable power supply, in terms of renewable sources, for power generation. This is expected to fuel the demand for installation of digital substations in upcoming smart cities as power generation is majorly done through r …
